Norway joins Finland, Sweden, and the UK in denouncing puberty blockers, cross-sex hormones, and ‘sex changes’ surgeries for minors confused about their gender.

The Norwegian Healthcare Investigation Board (NHIB) is the latest European body to announce that the so-called “affirmative model of care” for gender dysphoric minors is not supported by evidence and is advising against the use of cross-sex hormones, puberty blockers, and “sex change” surgeries for minors. The NHIB recommended that these “treatments” be classified as experimental and noted that the spike in children identifying as transgender is concerning.  

https://www.lifesitenews.com/blogs/another-european-country-just-dealt-a-devastating-blow-to-the-transgender-movement/?